Erstellt von fchar99
Insmed Inc. diskutieren
Insmed Inc.
WKN: A1JJA3 / Symbol: INSM / Name: Insmed / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
93,68 €
0,12 %
Insmed (INSM) had its "buy" rating reaffirmed by Roth Mkm.
Ratings data for INSM provided by MarketBeat
Insmed (INSM) had its price target lowered by JPMorgan Chase & Co. from $180.00 to $179.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (INSM) had its "overweight" rating reaffirmed by Cantor Fitzgerald.
Ratings data for INSM provided by MarketBeat
Insmed (INSM) had its "buy" rating reaffirmed by Guggenheim. They now have a $207.00 price target on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (INSM) had its price target raised by Wells Fargo & Company from $160.00 to $161.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (INSM) had its "buy" rating reaffirmed by HC Wainwright.
Ratings data for INSM provided by MarketBeat
Neueste Beiträge
Roth_Mkm in Calix Inc. diskutieren